EPISODE · Jan 31, 2024 · 22 MIN
Episode 43: Spoilt for choice - the many treatments now available for AMD and DME
from Talking Euretina · host Whipsmart Media
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes
NOW PLAYING
Episode 43: Spoilt for choice - the many treatments now available for AMD and DME
No transcript for this episode yet
Similar Episodes
May 17, 2026 ·37m
May 12, 2026 ·77m
May 8, 2026 ·39m